Accession Number | Gene Name | LPS (μg/ml) | Pearson Correlation Coefficient (r) | |||
---|---|---|---|---|---|---|
 |  |  | Control (PBS) | 1% H2O2 | 2% H2O2 | 3% H2O2 |
Down Regulated | ||||||
Adhesion | Â | Â | Â | Â | Â | Â |
   NM_001797 | cadherin 11, type 2, OB-cadherin (osteoblast) (CDH11) | 5 | 0.7715 | 0.9635 | 0.9903 | 0.9993 |
Anti-Oxidant | ||||||
   NM_001512 | glutathione S-transferase A4 (GSTA4) | 1 | 0.6140 | 0.8818 | 0.9360 | 0.9669 |
   NM_020998 | macrophage-stimulating protein (MST1) | 1 | 0.6693 | 0.9135 | 0.9589 | 0.9827 |
   NM_005400 | protein kinase C, epsilon (PRKCE) | 5 | 0.6189 | 0.8847 | 0.9382 | 0.9684 |
   NM_004624 | vasoactive intestinal peptide receptor 1 (VIPR1) | 5 | 0.7329 | 0.9462 | 0.9804 | 0.9953 |
   NM_001915 | cytochrome b-561 (CYB561) | 5 | 0.7711 | 0.9633 | 0.9902 | 0.9992 |
Antibacterial Factors | ||||||
   NM_020993 | B-cell CLL/lymphoma 7A (BCL7A) | 1 | 0.8045 | 0.9765 | 0.9963 | 0.9999 |
   NM_001735 | sapiens complement component 5 (C5) | 1 | 0.5590 | 0.8478 | 0.9100 | 0.9473 |
   NM_000565 | interleukin 6 receptor (IL6R) | 1 | 0.6850 | 0.9220 | 0.9648 | 0.9865 |
Apoptosis | ||||||
   NM_000435 | notch homolog 3 (Drosophila) (NOTCH3), | 1 | 0.7489 | 0.9536 | 0.9848 | 0.9973 |
   NM_001618 | poly (ADP-ribose) polymerase family, member 1 (PARP1), | 1 | 0.6838 | 0.9214 | 0.9643 | 0.9862 |
   NM_021136 | reticulon 1 (RTN1) | 1 | 0.6122 | 0.8807 | 0.9352 | 0.9663 |
   NM_000041 | apolipoprotein E (APOE) | 5 | 0.7164 | 0.9381 | 0.9754 | 0.9927 |
   NM_001964 | early growth response 1 (EGR1) | 5 | 0.7975 | 0.9739 | 0.9952 | 1.0000 |
Brain Function | ||||||
   NM_000027 | aspartylglucosaminidase (AGA) | 1 | 0.5997 | 0.8732 | 0.9295 | 0.9621 |
   NM_000441 | solute carrier family 26, member 4 (SLC26A4) | 5 | 0.7566 | 0.9571 | 0.9868 | 0.9981 |
   NM_004283 | RAB3D, member RAS oncogene family (RAB3D) | 5 | 0.8235 | 0.9830 | 0.9986 | 0.9988 |
   NM_003045 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 (SLC7A1) | 5 | 0.6901 | 0.9247 | 0.9666 | 0.9876 |
Cancer Marker | ||||||
   NM_016730 | folate receptor 1 (adult) (FOLR1) | 1 | 0.6441 | 0.8994 | 0.9489 | 0.9760 |
   NM_005635 | synovial sarcoma, X breakpoint 1 (SSX1) | 1 | 0.7612 | 0.9591 | 0.9879 | 0.9985 |
Cell Cycle Regulation | ||||||
   NM_005982 | SIX homeobox 1 (SIX1) | 5 | 0.6397 | 0.8969 | 0.9471 | 0.9748 |
   NM_005994 | T-box 2 (TBX2) | 5 | 0.6035 | 0.8755 | 0.9312 | 0.9634 |
Cytoskeletal Constitution and Rearrangement | ||||||
   NM_001621 | aryl hydrocarbon receptor (AHR) | 1 | 0.6673 | 0.9124 | 0.9582 | 0.9822 |
   NM_000269 | non-metastatic cells 1, protein (NM23A) expressed in (NME1) | 1 | 0.5921 | 0.8685 | 0.9260 | 0.9595 |
   NM_003289 | tropomyosin 2 (beta) (TPM2) | 1 | 0.7030 | 0.9314 | 0.9710 | 0.9903 |
   NM_015873 | villin-like (VILL) | 1 | 0.5310 | 0.8296 | 0.8956 | 0.9361 |
   NM_003023 | SH3-domain binding protein 2 (SH3BP2) | 5 | 0.7448 | 0.9517 | 0.9837 | 0.9969 |
Extra Cellular Matrix-Degrading Proteases | ||||||
   NM_007038 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 (aggrecanase-2) (ADAMTS5) | 1 | 0.6070 | 0.8776 | 0.9328 | 0.9646 |
Growth Factor and Related Protein Factors | ||||||
   NM_018127 | elaC homolog 2 (E. coli) (ELAC2) | 1 | 0.6819 | 0.9203 | 0.9636 | 0.9858 |
   NM_003506 | frizzled homolog 6 (Drosophila) (FZD6), | 1 | 0.7105 | 0.9352 | 0.9735 | 0.9917 |
   NM_018344 | solute carrier family 29 (nucleoside transporters), member 3 (SLC29A3) | 1 | 0.6177 | 0.8840 | 0.9376 | 0.9680 |
   NM_021724 | nuclear receptor subfamily 1, group D, member 1 (NR1D1) | 1 | 0.6802 | 0.9194 | 0.9630 | 0.9854 |
   NM_001012 | ribosomal protein S8 (RPS8) | 1 | 0.6111 | 0.8801 | 0.9347 | 0.9659 |
   NM_003087 | synuclein, gamma (breast cancer-specific protein 1) (SNCG) | 1 | 0.7776 | 0.9660 | 0.9916 | 0.9996 |
   NM_015906 | tripartite motif-containing 33 (TRIM33), | 1 | 0.7008 | 0.9303 | 0.9703 | 0.9898 |
   NM_000222 | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) | 1 | 0.6613 | 0.9091 | 0.9558 | 0.9807 |
   Y12863 | growth factor FIGF | 5 | 0.7831 | 0.9683 | 0.9927 | 0.9998 |
   NM_002086 | growth factor receptor-bound protein 2 (GRB2) | 1 | 0.6311 | 0.8919 | 0.9434 | 0.9722 |
   M35410 | insulin-like growth factor binding protein 2 (IGFBP2) | 1 | 0.6801 | 0.9194 | 0.9630 | 0.9854 |
   NM_001050 | somatostatin receptor 2 (SSTR2) | 1 | 0.9252 | 0.9996 | 0.9871 | 0.9658 |
   NM_016135 | ets variant gene 7 (TEL2 oncogene) (ETV7) | 5 | 0.6810 | 0.9198 | 0.9633 | 0.9856 |
   NM_006732 | FBJ murine osteosarcoma viral oncogene homolog B (FOSB) | 5 | 0.6889 | 0.9240 | 0.9662 | 0.9873 |
   NM_022963 | fibroblast growth factor receptor 4 (FGFR4) | 5 | 0.6720 | 0.9150 | 0.9600 | 0.9834 |
   NM_002957 | retinoid × receptor, alpha (RXRA) | 5 | 0.9264 | 0.9995 | 0.9866 | 0.9650 |
   NM_004630 | splicing factor 1 (SF1) | 5 | 0.8712 | 0.9955 | 0.9993 | 0.9904 |
   NM_005252 | v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) | 5 | 0.8257 | 0.9837 | 0.9988 | 0.9986 |
Hemostasis | ||||||
   NM_000624 | peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 (SERPINA5) | 1 | 0.6092 | 0.8790 | 0.9339 | 0.9653 |
Inflammation and Immunity | ||||||
   NM_000963 | cyclooxygenase-2 (COX2) | 1 | 0.5186 | 0.8213 | 0.8890 | 0.9308 |
Transfer of Cargo Between Intracellular Membrane Organelles | ||||||
   NM_016577 | RAB6B, member RAS oncogene family (RAB6B) | 1 | 0.7002 | 0.9299 | 0.9701 | 0.9897 |
Up Regulated | ||||||
Cancer Marker | ||||||
   NM_005814 | glycoprotein A33 (transmembrane) (GPA33) | 1 | -0.9658 | -0.9878 | -0.9589 | -0.9251 |
Cell Junction | ||||||
   NM_001943 | desmoglein 2 (DSG2) | 1 | -0.6663 | -0.9119 | -0.9578 | -0.9820 |
Cytoskeletal Constitution and Rearrangement | ||||||
   NM_002613 | 3-phosphoinositide dependent protein kinase-1 (PDPK1) | 1 | -0.5869 | -0.8653 | -0.9235 | -0.9577 |
Gene Transcription | ||||||
   NM_006180 | neurotrophic tyrosine kinase receptor, type 2 (NTRK2) | 1 | -0.6822 | -0.9205 | -0.9637 | -0.9858 |
   NM_013275 | nasopharyngeal carcinoma susceptibility protein; lz16/ankyrin repeat domain 11 (ANKRD11) | 1 | -0.7789 | -0.9666 | -0.9918 | -0.9997 |